Should You Change Doctors Mid-Treatment?

Start by requesting your records in writing, because that is the step with a legal deadline attached. Regulation 1.3.2 of the Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations 2002 states that where a request is made for medical records by the patient or an authorised attendant, it must be duly acknowledged and the documents issued within 72 hours. Regulation 7.2 lists refusing to provide them within that period as professional misconduct.

The rest of a clinic change is administrative, and it is reasonable to do it in this order:

1. Put the records request in writing and keep a dated copy. Regulation 1.3.1 requires records of indoor patients to be maintained for 3 years from the start of treatment, and section 23(c) of the ART (Regulation) Act 2021 requires ART clinics and banks to keep their records for at least ten years.
2. Ask for the discharge certificate. Section 21(h) of the ART Act requires the clinic to issue the commissioning couple or woman a discharge certificate stating details of the procedure performed.
3. Ask specifically for the parts a new clinician will need: stimulation protocol and doses, monitoring scans and hormone results, the embryology record, and any laboratory reports supporting the diagnosis.
4. Book the consultation at the new clinic before closing anything at the old one, so that any material still in storage has somewhere to go.
5. If frozen embryos or gametes are involved, resolve the transfer permission before you move — it is the slowest part.

Nothing in the sources retrieved here requires you to give a reason, and section 21(e) of the ART Act treats your treatment information as confidential, disclosable only to the National Registry database, in a medical emergency at the request of the commissioning couple to whom the information relates, or by order of a court.

No guideline retrieved for this article addresses transferring care during an ovarian stimulation cycle, and none sets out whether or how gonadotropin dosing should continue across a change of clinic. That absence is the honest answer, and it is worth knowing before you ask: a clinician declining to take over mid-stimulation is not necessarily being obstructive, because there is no agreed protocol for it.

What is documented is why the handover is not purely administrative. Dosing decisions during stimulation are driven by the monitoring in front of the clinician making them — scan findings and hormone levels on the day — so responsibility for the current cycle sits with whoever is doing that monitoring. Consent is also clinic-specific. In India the ART Act requires written informed consent of all parties before a clinic performs any procedure (section 22(1)). In the UK the HFEA states that before treatment can take place you are required by law to give informed written consent, on HFEA consent forms, and that you should be offered counselling before giving it.

So the practical sequence is: ask the prospective clinic whether it will accept a transfer at this point in the cycle, and ask the current clinic what completing the cycle involves. If neither answer is workable, the alternative is usually to finish or stop the current cycle and move before the next one starts, rather than to split a cycle between two teams.

In India this is the step that needs permission rather than paperwork. Section 29 of the ART (Regulation) Act 2021 prohibits the sale, transfer or use of gametes, zygotes and embryos — or information relating to them — to any party within or outside India, except in the case of transfer of your own gametes and embryos for personal use, with the permission of the National Board.

Two other limits sit around that. Storage of a donor gamete or an embryo is capped at ten years under section 28(2), after which it is allowed to perish or is donated for research with consent. And under section 22(4), either member of a commissioning couple may withdraw consent at any time before the embryos or gametes are transferred to the woman's uterus.

If the clinic closes rather than you leaving, section 23(d) requires it to transfer its records immediately to the central database of the National Registry, and section 23(c) requires the same transfer at the end of the ten-year retention period.

Section 21(f) of the ART Act requires every ART clinic and bank in India to maintain a grievance cell, with the manner of making a complaint to it prescribed by rules. That is a route that exists independently of whether you stay or leave.

In the UK the sequence is set out by the HFEA: complain to the clinic first and in writing, keeping a copy; if the clinic cannot resolve it, it should tell you how to escalate, and the HFEA advises that clinics treating self-funded patients join an independent Alternative Dispute Resolution scheme, while NHS-funded patients can use the relevant ombudsman after the internal complaints or PALS process. If you have been through the clinic's process and remain unhappy you can contact the HFEA, normally within six months of becoming aware of the problem.

Section 21(c) of the ART Act is also worth reading before deciding the relationship has broken down: it requires clinics to provide professional counselling about the implications and chances of success of the procedures they offer, to inform patients of the advantages, disadvantages, cost, medical side effects and risks including multiple pregnancy, and to help patients reach an informed decision. If that has not happened, asking for it is a smaller step than changing clinic.

No study retrieved for this article compares outcomes between patients who changed clinic and patients who stayed, so anyone quoting a figure for that is quoting something this article could not find.

Two pieces of context are documented. The first is that an unsuccessful cycle is the common outcome rather than the exceptional one: the HFEA tells patients that around three quarters of IVF treatments are unsuccessful. A single failed cycle is therefore weak evidence about a clinic, which is a different question from whether you are being communicated with properly.

The second is what makes people stop altogether. In an Israeli cohort where IVF was provided free and unlimited for a couple's first two children, 46 of 134 couples ceased treatment without achieving two children, and the reasons given were psychological burden (18), lost hope of success (13), divorce (6), medical staff recommendation (5), bureaucratic difficulty (3) and general medical condition (1) (Lande et al, Gynecological Endocrinology 2015;31(3):233-6). With cost removed, the burden of treatment still led the list — which is worth separating from a judgement about clinical quality when deciding what a change of clinic would actually fix.

ESHRE's 2015 guideline recommends, as a good practice point, that fertility staff offer patients the opportunity to discuss whether or not to take up recommended treatment and receive decisional support for that choice. How to read the success figures you are quoted in the meantime is covered in IVF Success Rates: How to Read the Numbers You Are Quoted, and what to compare when assessing a clinic in Choosing an IVF Clinic in India: What Actually Matters.

Several claims attach to this decision that the sources here do not support.

• That switching raises or lowers the chance of a live birth. No comparative study was retrieved in either direction.
• That there is a right point in a cycle to move. Nothing retrieved here addresses transfer of care during stimulation, including whether medication should continue unchanged.
• That patients commonly switch. No figure for how often this happens in India was retrieved, so the practice is undescribed rather than rare or common.
• That a clinic's published figures can be compared like for like. The ART Act establishes the National Assisted Reproductive Technology and Surrogacy Registry as a central database of clinics and outcomes (sections 9 to 11), but no source retrieved here shows patient-facing, clinic-level outcome data published from it.
• That a failed cycle indicates poor care. The HFEA's own patient information puts the unsuccessful proportion of IVF treatments at around three quarters.
• That records can be withheld until dues are settled. Regulation 1.3.2 sets a 72-hour deadline for issuing requested records and regulation 7.2 makes refusal professional misconduct; no exception for outstanding payment appears in the text retrieved.

What the sources do support: the records are obtainable on a deadline, the discharge certificate is your entitlement, embryos move only with National Board permission, every clinic must run a grievance cell, and the clinical question of whether a different plan would help is separate from the service question that usually prompts the move. If it is the plan you doubt, After a Failed IVF Cycle: What Is Worth Investigating sets out what is worth testing before repeating anything.